A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Cholangiocarcinoma
Related studies linked through entity extraction aliases.
Lenvatinib in Patients With Previously Treated Advanced Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of BMS-936558 With SBRT After Induction Chemotherapy in Cholangiocarcinoma
- Status
- TERMINATED
- Phase
- PHASE2
Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Observational Study on Patients With Hepatobiliary Tumors
- Status
- UNKNOWN
- Phase
- N/A
ENHANCED RECOVERY AFTER BILIARY TRACT SURGERY
- Status
- UNKNOWN
- Phase
- NA
Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care
- Status
- WITHDRAWN
- Phase
- NA
Prospective Evaluation of Biliary Tissue Sampling With ERCP
- Status
- COMPLETED
- Phase
- N/A
DNA Methylation Biomarker for Diagnosis of Cholangiocarcinoma in Patients With Bile Duct Stricture
- Status
- COMPLETED
- Phase
- NA
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
- Status
- AVAILABLE
- Phase
- N/A
Combination of Trametinib (MEK Inhibitor) and Hydroxychloroquine (HCQ) (Autophagy Inhibitor) in Patients With KRAS Mutation Refractory Bile Tract Carcinoma (BTC).
- Status
- TERMINATED
- Phase
- PHASE2
A Study of ICP-192 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
- Status
- TERMINATED
- Phase
- N/A
REFOCUS: A First-in-Human Study of Highly Selective FGFR2 Inhibitor, RLY-4008, in Patients With ICC and Other Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Liver Cancer Registry Platform
- Status
- RECRUITING
- Phase
- N/A
TCF-001 TRACK (Target Rare Cancer Knowledge) Study
- Status
- RECRUITING
- Phase
- NA
PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study)
- Status
- COMPLETED
- Phase
- NA